PEGCETACOPLAN
pegcetacoplan 1.08 g/20 mL injection, 20 mL vial
PEGCETACOPLAN (13185Y)
13185Y
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: First continuing treatment
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Subsequent continuing treatment
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangement 1
(Complement 5 (C5) inhibitor inexperienced patients)
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangement 2
(Complement 5 (C5) inhibitor experienced patients)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $4,343.86 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Empaveli | |||||